Name
Akeso Inc.
Company Description
Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease, and other major therapeutic areas. Akeso has successfully promoted the commercialization of three innovative biological drugs (one out-licensed drug).
Website
Product Categories (5)
First-Time Exhibitor
First Time Exhibitor
Yes
Address
Zhongshan City,
China
China
Recognition
